Ensitrelvir in hospitalized patients with COVID-19 who were moderately to severely immunocompromised: a single-center cohort study
Therapeutic Advances in Infectious Disease
Published online on August 04, 2026
Abstract
Therapeutic Advances in Infectious Disease, Volume 13, January-December 2026.
Background:Immunocompromised patients have a risk of severe COVID-19.Objectives:To describe the outcomes of ensitrelvir in hospitalized immunocompromised patients with COVID-19, with remdesivir as a reference.Design:Single-center retrospective cohort ...
Background:Immunocompromised patients have a risk of severe COVID-19.Objectives:To describe the outcomes of ensitrelvir in hospitalized immunocompromised patients with COVID-19, with remdesivir as a reference.Design:Single-center retrospective cohort ...